Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134907

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	100,000 Genomes Project
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to evaluate the 100,000 Genomes Project.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	269788
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>As a Government Major Project, the 100,000 Genomes Project has been under regular review by the Infrastructure and Projects Authority (IPA) which provides independent assurance of the most complex and strategically significant projects across Government. As part of this, the 100,000 Genomes Project has undergone several significant reviews which considered the Project’s delivery, requiring the collation of extensive documentation evidencing the progress of the Project and several days of interviews with key stakeholders. Conclusions of each review were shared across delivery partners to inform successful delivery of the Project.</p><p>The Department, Genomics England and NHS England recognised the importance in embedding robust testing, assessment and evaluation throughout the delivery of the Project to inform the introduction of whole genome sequencing in the National Health Service under the new Genomics Medicine Service.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/07/2019 11:40:47 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4370 label Biography information for Jess Phillips

1135034

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 30 January 2019 to Question 214478 and of 26 February to Question 223137, if he will (a) discuss that difference in clinical practice with the Royal College of Obstetricians and Gynaecologists and (b) ask that college to review its clinical guidelines.
	tabling member constituency	Congleton
	tabling member printed	Fiona Bruce
	uin	269708
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>The Department has brought this issue to the attention of the Royal College of Obstetricians and Gynaecologists (RCOG). It is for the RCOG to consider whether to revise its guidelines having considered the available evidence.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 01/07/2019 13:22:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3958 label Biography information for Fiona Bruce

1134971

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the level of alcohol-related mortality rates in each National Statistics Socio economic classification in the most recent period for which figures are available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	269652
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>Public Health England’s evidence review ‘The Public Health Burden of Alcohol and the Effectiveness and Cost-Effectiveness of Alcohol Control Policies’ highlighted that in the English population, rates of alcohol-specific and related mortality increase as levels of deprivation increase and alcohol-related liver disease is strongly related to the socioeconomic gradient.</p><p> </p><p>The NHS Long Term Plan signalled our support for improving treatment for patients in deprived areas with expert Alcohol Care Teams working in the 25% worst affected parts of the country supporting patients and their families who have issues with alcohol misuse. It is estimated that these new measures could prevent 50,000 admissions and almost 250,000 bed days over the next five years. The Government will continue to be mindful of social inequalities whilst developing policies to tackle alcohol harms.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 01/07/2019 15:52:49 answering member 4455 label Biography information for Seema Kennedy
	tabling member	534 label Biography information for Chris Ruane

1135038

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ambulance Services: Essex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to additional blue light emergency patient transfers between hospitals proposed in the mid/south Essex sustainability and transformation plan, what estimate has been made of the number of additional emergency transfers each day; in which financial year the contract for those transfers is due to be let; which element of the NHS will fund that contract; whether the contract will be let competitively; and whether the East of England Ambulance Service NHS Trust has the capacity to service that contract.
	tabling member constituency	Rayleigh and Wickford
	tabling member printed	Mr Mark Francois
	uin	269667
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>The Mid and South Essex Sustainability and Transformation Partnership (STP) has set out proposals to change how they provide specialist care across the three hospitals in their STP, to improve access for their population. The proposals are currently under review by the Independent Reconfiguration Panel.</p><p>The proposals include the development of a ‘treat and transfer’ model which would allow a small number of patients within specified conditions to be stabilised at their local accident and emergency department and then, if appropriate, transferred using a specialist clinical transfer service to a different hospital to receive ongoing specialist treatment and care. If this model is utilised, it is anticipated that 15 additional patients each day could be transferred, increasing the total number transferred each day to 29.</p><p>As the proposals are currently subject to a referral to the Independent Reconfiguration Panel, the commissioning of any service will not commence prior to the resolution of that process. The Mid and South Essex STP has secured £118 million of capital investment to support these plans. A full competitive tender process will be undertaken if the proposals are pursued.</p><p>Once the final service specification has been agreed and issued to the market, the East of England Ambulance Service NHS Trust and other providers will be in a position to determine their capacity to fulfil the contract, which would be assessed through any procurement process.</p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 01/07/2019 15:16:40 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1444 label Biography information for Mr Mark Francois

1134829

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what research his Department has undertaken (a) directly, (b) through research councils and (c) with international partners on antimicrobial resistance.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	269618
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The Department is investing over £1 billion a year in health research through the National Institute for Health Research (NIHR). The NIHR supports a wide portfolio of research on antimicrobial resistance (AMR) through various funding streams. In the United Kingdom, investment includes £32 million of capital funding to support AMR research, £19.1 million for AMR research at four NIHR Biomedical Research Centres, and £8.8 million for two NIHR Health Protection Research Units on Healthcare Associated Infections and Antimicrobial Resistance.</p><p>The NIHR also supports research into AMR in low and middle-income countries (LMICs), with official development assistance (ODA) funding through the NIHR Global Health Research programme. Investment includes support for the NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance, and the NIHR Global Health Research Group on Genomic Surveillance of Malaria in West Africa.</p><p>Working through partnerships with other UK funders, the NIHR Global Health Research programme also supports cross-Research Council initiatives including one led by the Medical Research Council for research into AMR in a global context, and another led by the Economic and Social Research Council to expand understanding of how behaviour within and beyond the healthcare system impacts on AMR.</p><p>In addition, the Department has allocated over £50 million of ODA over five years to AMR research through the Global AMR Innovation Fund. This research is delivered through a range of mechanisms and delivery partners, including research councils such as the Biotechnology and Biological Sciences Research Council and Innovate UK, and international partners including the Wellcome Trust, Bill and Melinda Gates Foundation, the United States and German governments, and Canada’s International Development Research Centre.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/07/2019 11:34:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	252 label Biography information for Dr David Drew

1134888

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autism and Learning Disability: Newcastle-under-Lyme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that constituents with learning disabilities or autism, in Newcastle-under-Lyme, are able to access inpatient facilities close to home.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	269659
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>Adult non-secure inpatient services for people with learning disabilities and/or autism in Newcastle-Under-Lyme are commissioned by the Newcastle-Under-Lyme Clinical Commissioning Group (CCG). Local CCGs should ensure that patients with a learning disability and/or autism have access to an inpatient bed when they need it.</p><p>Adult secure inpatient services and Child and Adolescent Mental Health Services (CAMHS) Tier 4 inpatient beds for children and young people with learning disabilities and/or autism in Newcastle-Under-Lyme are commissioned by the NHS England Specialised Commissioning Team in the West Midlands, which will always look at prioritising meeting clinical needs as locally as possible.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 01/07/2019 15:12:00 answering member 1585 label Biography information for Stephen Hammond
	tabling member	1436 label Biography information for Paul Farrelly

1134876

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the cost is of a single whole genome sequencing test for (a) blood cancers and (b) other cancer types.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	269721
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The National Genomic Test Directory outlines which genomic tests are commissioned by the National Health Service in England, the technology by which they are available, and the patients who will be eligible to access to a test. The Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as whole genome sequencing. As the price of whole genome sequencing falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients. More information on the Directory is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>There is considerable variation in the reported costs of genomic analysis. For Genomics England, during the 100,000 Genomes project, these were in order of £2,500 per cancer patient. This included sequencing both the patient’s normal genome and their tumour, as well as the running costs of undertaking both the sequencing and bioinformatics for analysis and interpretation.</p><p>Health Education England established the Genomics Education Programme to support NHS staff to build the knowledge, skills and experience to deliver a whole genome sequencing service. This programme is being embedded into organisations to enable long-term sustainability of the multi-disciplinary clinical workforce.</p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 269720 269722 question first answered 05/07/2019 09:26:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4056 label Biography information for Nic Dakin

1135018

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cataracts: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information the Department holds on the number of NHS Clinical Commissioning Groups that follow the NICE 2017 guideline, NG77, on cataract surgery.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	269606
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>The Department holds no information on the number of clinical commissioning groups (CCGs) which follow the National Institute for Health and Care Excellence (NICE) 2017 guideline, NG77.</p><p> </p><p>NICE clinical guidelines are based on a thorough assessment of the available evidence and are developed through engagement with stakeholders. They represent best practice and CCGs are expected to take them fully into account when planning and commissioning high-quality services healthcare services that meet the needs of their local population, including cataract surgery.</p><p>NHS England is responsible for holding CCGs to account to ensure they are commissioning services that meet the needs of their local populations.</p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 269607 question first answered 01/07/2019 15:46:19 answering member 4455 label Biography information for Seema Kennedy
	tabling member	207 label Biography information for Sir Vince Cable

1135020

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cataracts: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to promote best practice across Clinical Commissioning Groups on the NICE 2017 guideline, NG77, on cataract surgery.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	269607
	answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>The Department holds no information on the number of clinical commissioning groups (CCGs) which follow the National Institute for Health and Care Excellence (NICE) 2017 guideline, NG77.</p><p> </p><p>NICE clinical guidelines are based on a thorough assessment of the available evidence and are developed through engagement with stakeholders. They represent best practice and CCGs are expected to take them fully into account when planning and commissioning high-quality services healthcare services that meet the needs of their local population, including cataract surgery.</p><p>NHS England is responsible for holding CCGs to account to ensure they are commissioning services that meet the needs of their local populations.</p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 269606 question first answered 01/07/2019 15:46:19 answering member 4455 label Biography information for Seema Kennedy
	tabling member	207 label Biography information for Sir Vince Cable

1134899

	registered interest
	date	26/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS long-term plan, what assessment he has made of the potential effect on healthcare delivery of reducing the number of clinical commissioning groups to match the number of sustainability and transformation partnerships.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	269781
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>Sustainability and transformation partnerships (STPs) and integrated care systems (ICS) are fundamentally about bringing National Health Service providers, commissioners, local authorities, and other health and care services together to propose how they, at local level, can improve the way that health and care is planned and delivered in a more person-centred and coordinated way.</p><p>The most developed STPs have evolved into ICS, an even closer partnership between NHS organisations, local councils and other relevant organisations, which take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve.</p><p>The NHS Long Term Plan set out the ambition for ICS to cover the whole of England by April 2021. The NHS Long Term Plan sets out that “every ICS will need streamlined commissioning arrangements to enable a single set of commissioning decisions at system level. This will typically involve a single Clinical Commissioning Group (CCG) for each ICS area”. However, this will need to reflect local circumstances, and NHS England is not intending to impose this centrally. NHS England is working with ICS and local areas to determine the best configuration of CCGs.</p><p>CCGs have a legal right to apply for a merger and it is for NHS England to decide whether to approve a merger. This is an operational decision, and so sits with NHS England. There are a number of specific legal factors and further criteria that NHS England will consider when deciding whether to agree the merger. The application process and criteria applied for CCG mergers is available in the Procedures for clinical commissioning groups to apply for constitution change, merger or dissolution guidance.</p><p>The criteria include the proposed new CCG demonstrating alignment with (or within) the local STP/ICS to provide the most logical footprint for local implementation of the NHS Long Term Plan. CCGs must also include evidence of providing strategic, integrated commissioning to support population health; whilst ensuring that the move to a larger geographical footprint will not be at the expense of local accountability, or the proposed new CCG’s ability to engage with, and consider the needs of, local communities. Before a merger takes place, the CCG must also demonstrate that they have engaged with and seriously considered the views of their local general practitioners and local Healthwatch. In all cases, CCGs’ legal accountability to NHS England remains the same, regardless of the size of the CCG.</p><p>More broadly, we support NHS England’s intention to streamline commissioning arrangements, as NHS England expect that this will make it easier for the NHS to manage resources, make strategic decisions, and reduce unnecessary bureaucracy.</p><p> </p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 269782 269783 269784 269785 question first answered 05/07/2019 13:24:50 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4620 label Biography information for Ellie Reeves